Director of NIBIB to Give Keynote Talk at 3rd Imaging in Drug Development Conference – Mar. 17-18, San Diego
Monrovia, CA, January 26, 2008 --(PR.com)-- Roderic Pettigrew, Director at the National Institute of Biomedical Imaging & Bioengineering, NIH will give the keynote presentation at GTCbio’s 3rd Imaging in Drug Development conference March 17-18, 2008 in San Diego, CA.
Dr. Pettigrew will discuss the importance of imaging in 21st century healthcare and its essential involvement in many aspects of the drug discovery process. Dr. Pettigrew’s research at the NIBIB focuses on combining the physical and biological sciences to develop new technologies that improve health. Their goal is to accelerate the pace of discovery and speed the development of biomedical technologies that prevent and treat illnesses.
Dr. Pettigrew is the first director of the National Institute of Biomedical Imaging and Bioengineering (NIBIB). Before being appointed as director, he was a Professor of Radiology Medicine at Emory University in Atlanta, Georgia. He also served as Director of the Emory Center for Magnetic Resonance Research at Emory University School of Medicine. He was also Professor of Bioengineering at the Georgia Institute of Technology.
Presenting organizations at the 3rd Imaging in Pre-clinical & Clinical Drug Development conference include GlaxoSmithKline, Pfizer, Abbott, Schering-Plough, Bristol-Myers Squibb, GE Healthcare, Siemens, NIH, UCLA, 3-D Imaging, and more.
The 3rd Imaging in Pre-clinical & Clinical Drug Development conference features presentations on novel imaging methods and technology, imaging in drug development and therapy, imaging applications in CNS, imaging applications in oncology and imaging applications in the cardiovascular system. For more information, visit www.gtcbio.com.
About GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, customerservices@gtcbio.com
###
Dr. Pettigrew will discuss the importance of imaging in 21st century healthcare and its essential involvement in many aspects of the drug discovery process. Dr. Pettigrew’s research at the NIBIB focuses on combining the physical and biological sciences to develop new technologies that improve health. Their goal is to accelerate the pace of discovery and speed the development of biomedical technologies that prevent and treat illnesses.
Dr. Pettigrew is the first director of the National Institute of Biomedical Imaging and Bioengineering (NIBIB). Before being appointed as director, he was a Professor of Radiology Medicine at Emory University in Atlanta, Georgia. He also served as Director of the Emory Center for Magnetic Resonance Research at Emory University School of Medicine. He was also Professor of Bioengineering at the Georgia Institute of Technology.
Presenting organizations at the 3rd Imaging in Pre-clinical & Clinical Drug Development conference include GlaxoSmithKline, Pfizer, Abbott, Schering-Plough, Bristol-Myers Squibb, GE Healthcare, Siemens, NIH, UCLA, 3-D Imaging, and more.
The 3rd Imaging in Pre-clinical & Clinical Drug Development conference features presentations on novel imaging methods and technology, imaging in drug development and therapy, imaging applications in CNS, imaging applications in oncology and imaging applications in the cardiovascular system. For more information, visit www.gtcbio.com.
About GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, customerservices@gtcbio.com
###
Contact
GTCbio
Rania Hafez
626-256-6405
http://www.gtcbio.com
Rania Hafez
626-256-6405
http://www.gtcbio.com
Contact
Categories